CN 03-2024 - Red Book Updates Batch 3 v1.pdf (2MB)
7.7.11: Cryoprecipitate for Neonates and Infants, Leucocyte Depleted The component represents a source of concentrated FVIII, and von Willebrand factor, fibrinogen, FXIII and fibronectin…
7.5.5: Cryoprecipitate, Pooled, Pathogen Reduced, Leucocyte Depleted The component provides a concentrated source of FVIII, and von Willebrand factor, fibrinogen, Factor XIII and fibrone…
7.5.2: Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted Fresh Frozen Plasma, Pathogen Reduced, Leucocyte Depleted, is plasma that has been obtained from whole blood or by aphere…
Redundant Component A4.5: Plasma, Cryoprecipitate Depleted, Leucocyte Depleted The supernatant plasma removed during the preparation of Cryoprecipi…
Redundant Component A4.3 Convalescent Plasma (COVID-19), FFP, for Neonates and Infants, Leucocyte Depleted Convalescent Plasma (COVID-19), FFP…
Redundant Component A4.2 Convalescent Plasma (COVID-19), FFP, Leucocyte Depleted Plasma that has been obtained from whole blood or by apheresi…
Redundant Component A4.1 Granulocytes, Apheresis A component prepared from anticoagulated blood, which is separated into components by a suitable a…
Blood Components for Contingency Use A5.2: Platelets, Apheresis, Leucocyte Depleted, at Reduced Dose as a Contingency A single-donor platelet compo…
Blood Components for Contingency Use A5.1: Red Cells in Additive Solution, Leucocyte Depleted, Extended…
Provisional component A3.10: Convalescent Plasma (VCOV-19), FFP, Leucocyte Depleted Plasma that has been obtained by apheresis from vaccinated dono…
Provisional Component A3.6: Whole Blood, Leucocyte Depleted, for Clinical Studies A unit of blood collected into CPD anticoagulant, containing red …
Provisional Component A3.5: Red Cells and Plasma, Leucocyte Depleted A unit of blood collected into CPD anticoagulant, containing less than 1 &time…
Provisional Component A3.4: Red Cells, Rejuvenated and Washed, Leucocyte Depleted A red cell component, containing less than 1 × 106
Provisional Component A3.2: Red Cells in Additive Solution, Leucocyte Depleted, Pathogen Reduced A red cell component containing less than 1 ×…
Provisional Component A3.1: Platelets in Additive Solution and Plasma, Leucocyte Depleted, Pathogen Reduced A platelet concentrate, derived from bu…
7.7.12: Cryoprecipitate for Neonates and Infants, Pathogen Reduced, Leucocyte Depleted The component provides a source of concentrated FVIII, and von Willebrand factor, fibrino…
7.7.7: Platelets for Neonatal Use, Leucocyte Depleted An apheresis platelet component for neonatal use that contains less than 1 × 106 leucocytes per starting component.…
7.7.8: Platelets in Plasma and Additive Solution for Neonatal Use, Leucocyte Depleted An apheresis platelet component for neonatal use which contains less than 1 × 106 …
7.7.6: Platelets for Intrauterine Transfusion, Leucocyte Depleted A hyperconcentrated platelet component for intrauterine transfusion, prepared by apheresis, that contains less than 1&n…
7.7.5: Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted A red cell component suitable for top-up or large-volume transfusion of neonates and infants under 1 y…
7.7.4: Red Cells for Neonates and Infants, Leucocyte Depleted A red cell component suitable for neonates and infants under 1 year that contains less than 1 × 106 leucoc…
7.7.2: Whole Blood for Exchange Transfusion, Leucocyte Depleted A component for exchange or large-volume transfusion of neonates, containing less than 1 × 106 leucocyte…
7.4.4: Platelets in Additive Solution, Leucocyte Depleted A platelet concentrate derived from buffy coats or apheresis, which contains less than 1 × 106 leucocytes and …
7.4.3: Platelets, Pooled, Buffy Coat Derived, in Additive Solution and Plasma, Leucocyte Depleted A platelet concentrate, derived from buffy coats, which contains less than 1 × 10…